Genocea wins award for in vitro immune system

Genocea Biosciences has been recognized as the best vaccine startup company at a meeting of the World Vaccine Congress in Washington D.C. Genocea boasts the ability to create the human immune system in vitro, a scientific feat that allows its researchers to test which antigens get the best immune response.

"This award is a testament to the dedication and vision of our scientific founder Darren Higgins, the tireless efforts of our founding team, and to the world-renowned vaccine industry experts who have joined Genocea," said Robert Paull, co-founder and president of Genocea Biosciences. "Leaders of some of the most successful vaccine companies, such as Merck Vaccines, Wyeth Vaccines, and CSL Ltd., have validated our technology as an industry-transforming platform. We're honored and very appreciative of the recognition."

- read the press release

ALSO: In all, there were seven award categories at the conference. Find a list of all the winners here.

Suggested Articles

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.

Former FDA Commissioner Scott Gottlieb says 40% of the population needs to be vaccinated to achieve COVID-19 herd immunity.

CanSino Bio, Moderna and a collaboration between Oxford Univeristy and AstraZeneca are frontrunners, but they all face hurdles shared and unique.